Birdwatch Archive

Birdwatch Note Rating

2024-12-27 21:07:45 UTC - NOT_HELPFUL

Rated by Participant: 801EF47667BB4A265482C460A08B6BB8CD8D4399730F8E355209F79C3722D4ED
Participant Details

Original Note:

According to journalists, "SoftBank led an investment of $1.1 billion in Roivant. The investment wasn’t about getting in on Axovant; SoftBank thought intepirdine was unlikely to succeed, the person said. But SoftBank was seeking to invest in [his] wider drug portfolio..." https://www.nytimes.com/2023/06/27/us/politics/vivek-ramaswamy-wealth.html

All Note Details

Original Tweet

All Information

  • noteId - 1872646718988194157
  • participantId -
  • raterParticipantId - 801EF47667BB4A265482C460A08B6BB8CD8D4399730F8E355209F79C3722D4ED
  • createdAtMillis - 1735333665937
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - NOT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 1
  • notHelpfulSourcesMissingOrUnreliable - 1
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 1
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 1
  • notHelpfulNoteNotNeeded - 1
  • ratingsId - 1872646718988194157801EF47667BB4A265482C460A08B6BB8CD8D4399730F8E355209F79C3722D4ED